Benzinga | Feb 18, 2021 08:27AM EST

Morgan Stanley Maintains Overweight on Exelon, Lowers Price Target to $55

Morgan Stanley analyst Stephen Byrd maintains Exelon (NASDAQ:EXC) with a Overweight and lowers the price target from $56 to $55.